Device
MID-C
MID-C is a medical device with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Terminated(1)
Other(1)
Detailed Status
Completed1
unknown1
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A2 (100.0%)
Trials by Status
completed133%
unknown133%
withdrawn133%
Recent Activity
0 active trials
Showing 3 of 3
unknownnot_applicable
Minimal Invasive Deformity Correction (MID-C) System for Early Onset Scoliosis
NCT03519321
withdrawnnot_applicable
Limited-efficacy Testing of Spring Distraction System (SDS) and Unilateral One-way Rod (MID-C) for Early Onset Scoliosis
NCT04003233
completed
Feasibility Evaluation Study of the MID-C Device
NCT03071471
Clinical Trials (3)
Showing 3 of 3 trials
NCT03519321Not Applicable
Minimal Invasive Deformity Correction (MID-C) System for Early Onset Scoliosis
NCT04003233Not Applicable
Limited-efficacy Testing of Spring Distraction System (SDS) and Unilateral One-way Rod (MID-C) for Early Onset Scoliosis
NCT03071471
Feasibility Evaluation Study of the MID-C Device
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3